Direkt zum Inhalt
Merck

Catalysis and sulfa drug resistance in dihydropteroate synthase.

Science (New York, N.Y.) (2012-03-03)
Mi-Kyung Yun, Yinan Wu, Zhenmei Li, Ying Zhao, M Brett Waddell, Antonio M Ferreira, Richard E Lee, Donald Bashford, Stephen W White
ZUSAMMENFASSUNG

The sulfonamide antibiotics inhibit dihydropteroate synthase (DHPS), a key enzyme in the folate pathway of bacteria and primitive eukaryotes. However, resistance mutations have severely compromised the usefulness of these drugs. We report structural, computational, and mutagenesis studies on the catalytic and resistance mechanisms of DHPS. By performing the enzyme-catalyzed reaction in crystalline DHPS, we have structurally characterized key intermediates along the reaction pathway. Results support an S(N)1 reaction mechanism via formation of a novel cationic pterin intermediate. We also show that two conserved loops generate a substructure during catalysis that creates a specific binding pocket for p-aminobenzoic acid, one of the two DHPS substrates. This substructure, together with the pterin-binding pocket, explains the roles of the conserved active-site residues and reveals how sulfonamide resistance arises.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Sulfathiazol
Supelco
Sulfathiazol, VETRANAL®, analytical standard